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Background: In the last decade, several new treatments of truncal
varicose veins have been introduced. Of these new therapies, endovenous
laser therapy (EVLT) is one of the most widely accepted and used treatment
options for incompetent greater and lesser saphenous veins.
Objective: The objective of this report is to inform clinicians about the
EVLT procedure and to review its efficacy and safety in treatment of truncal
varicose veins. Also, we discuss some of the underlying theoretical principles
and laser parameters that affect EVLT.
Methods: We carried out a literature review of EVLTs efficacy and
safety. We included reports that included 100 or more limbs with a fol-
low-up of at least 3 months. The principals and procedure of EVLT are
described. Of the laser parameters, mode of administration, wavelength,
fluence, wattage and pullback speed are discussed.
Conclusion: EVLT appears to be a very effective and safe option in the
treatment of varicose veins but large randomized comparative studies are
needed.
Mechanisms in Experimental Venous Valve Failure and their Modifi-
cation by Daflon 500 mgReaders can access EJVES articles at http://intl.eObjectives: To characterize the acute response of the vein wall to
venous hypertension and associated altered fluid shear stress and to test the
effect of micronized purified flavonoid fraction (MPFF, Daflon® 500), on
this response.
Material and methods: A femoral arteriovenous fistula was created in
Wistar rats (n  48). A cohort of 24 rats received oral treatment with MPFF
(100 mg/kg/day body weight), 24 rats underwent the arteriovenous fistula
procedure and received no treatment. At days 1, 7 and 21 the animals (n  8
at each time point) were killed. Experimental parameters measured included
limb circumference, blood flow at the sapheno-femoral junction, leukocyte
infiltration and gelatinase activity (matrix metalloproteinase, MMP).
Results: The acute rise in venous hypertension was accompanied by
limb edema and venous reflux together with an eventual loss of valve leaflets
in the saphenous vein. There was an increase in granulocyte andmacrophage
infiltration into the venous wall and the surrounding tissue, and a lesser
increase in T- and B-lymphocyte infiltration. These changes were accompa-
nied by a local increase in the proteolytic enzymes, MMP-2 and MMP-9.
Administration of MPFF reduced the edema and lessened the venous reflux
produced by the acute arteriovenous fistula. Decreased levels of granulocyte
and macrophage infiltration into the valves were also observed compared
with untreated animals.
Conclusions: Venous hypertension caused by an arteriovenous fistula
resulted in the development of venous reflux and an inflammatory reaction in
venous valves culminating in their destruction. MPFF was able to delay thePascarella L., LulicD., PennA.H., AlsaighT., Lee J., ShinH., KapurV., Bergan
J.J., Schmid-Schönbein G.W. Eur J Vasc Endovasc Surg 2007;35:102-110.
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